Dietmar Berger, M.D., Ph.D., joined Gilead Sciences as chief medical of | Dietmar Berger became Gilead Sciences’ new chief ...

GSK PLC GSK shares rallied 1.20% to £15.12 Thursday, on what proved to be an all-around favorable trading session for the ...

GSK PLC closed 11.54% below its 52-week high of £16.79, which the company reached on September 9th.

According to J&J, Akeega is the first PARP inhibitor combination that’s proven effective treating earlier-stage prostate ...

Mumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Chinmay Sharma, Executive Vice President - ...

Investec PLC and Ltd - Sandton-based financial services - Director Nishlan Samujh sells 59,302 shares at 528.54 pence each on Friday. Worth total GBP313,434.79. In addition, says Director Fani Titi ...

Stephen Hemsley returned to the top job last month after the healthcare giant reported its first earnings miss since 2008.

With that, Theravance expects its lifetime value from the inhaler to come out to $1.52 billion. The drug stems from a 2002 ...

(Alliance News) - GSK PLC on Monday announced the US Food & Drug Administration has accepted for review the new drug application for its liver disease treatment, linerixibat.

Stocks of several companies, including Advani Hotels & Resorts (India), Bajaj Finance, GlaxoSmithKline Pharmaceuticals, ...

Arrowhead Pharmaceuticals, Inc.'s deal with Sarepta expands its pipeline, but limited plozasiran market and competition ...